{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:02:52Z","timestamp":1784678572688,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["325011079"],"award-info":[{"award-number":["325011079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73692-y","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:05:10Z","timestamp":1779879910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1"],"prefix":"10.1038","volume":"17","author":[{"given":"Ziyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-7597","authenticated-orcid":false,"given":"Jialu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6840-5336","authenticated-orcid":false,"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cantao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-7441","authenticated-orcid":false,"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8590-9525","authenticated-orcid":false,"given":"Dong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-8278","authenticated-orcid":false,"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"73692_CR1","unstructured":"World Health Organization. World malaria report 2024: addressing inequity in the global malaria response (WHO, 2024)."},{"key":"73692_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207\u2013211 (2015).","journal-title":"Nature"},{"key":"73692_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93487-3","volume":"15","author":"J Huang","year":"2025","unstructured":"Huang, J. et al. Global burden of malaria before and after the COVID-19 pandemic based on the global burden of disease study 2021. Sci. Rep. 15, 9113 (2025).","journal-title":"Sci. Rep."},{"key":"73692_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S1473-3099(22)00273-0","volume":"22","author":"AM Samuels","year":"2022","unstructured":"Samuels, A. M. et al. Efficacy of RTS,S\/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5\u201317 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial. Lancet Infect. Dis. 22, 1329\u20131342 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"73692_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","volume":"403","author":"MS Datoo","year":"2024","unstructured":"Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.  Lancet 403, 533\u2013544 (2024).","journal-title":"Lancet"},{"key":"73692_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"J Achan","year":"2011","unstructured":"Achan, J. et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar. J. 10, 144 (2011).","journal-title":"Malar. J."},{"key":"73692_CR7","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.pharmthera.2020.107672","volume":"216","author":"Z-N Lei","year":"2020","unstructured":"Lei, Z.-N. et al. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacol. Ther. 216, 107672 (2020).","journal-title":"Pharmacol. Ther."},{"key":"73692_CR8","first-page":"CD012656","volume":"8","author":"R Milligan","year":"2020","unstructured":"Milligan, R., Daher, A., Villanueva, G., Bergman, H. & Graves, P. M. Primaquine alternative dosing schedules for preventing malaria relapse in people with plasmodium vivax. Cochrane Database Syst. Rev. 8, CD012656 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"73692_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1017\/S0031182025000071","volume":"152","author":"T Masserey","year":"2025","unstructured":"Masserey, T., Braunack-Mayer, L., Miller, R. S., M\u00f6hrle, J. J. & Penny, M. A. A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention. Parasitology 152, 133\u2013142 (2025).","journal-title":"Parasitology"},{"key":"73692_CR10","doi-asserted-by":"publisher","unstructured":"Dhorda, M. et al. Artemisinin-resistant malaria in Africa demands urgent action. Science https:\/\/doi.org\/10.1126\/science.adp5137 (2024).","DOI":"10.1126\/science.adp5137"},{"key":"73692_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/322858","volume":"184","author":"TE Wellems","year":"2001","unstructured":"Wellems, T. E. & Plowe, C. V. Chloroquine-resistant malaria. J. Infect. Dis. 184, 770\u2013776 (2001).","journal-title":"J. Infect. Dis."},{"key":"73692_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht, K. J., Mok, S. & Fidock, D. A. Molecular mechanisms of drug resistance in plasmodium falciparum malaria. Annu. Rev. Microbiol. 74, 431\u2013454 (2020).","journal-title":"Annu. Rev. Microbiol."},{"key":"73692_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco, B., Leroy, D. & Fidock, D. A. Antimalarial drug resistance: linking plasmodium falciparum parasite biology to the clinic. Nat. Med. 23, 917\u2013928 (2017).","journal-title":"Nat. Med."},{"key":"73692_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nrmicro2239","volume":"7","author":"RT Eastman","year":"2009","unstructured":"Eastman, R. T. & Fidock, D. A. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat. Rev. Microbiol. 7, 864\u2013874 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"73692_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1473-3099(18)30071-9","volume":"18","author":"D M\u00e9nard","year":"2018","unstructured":"M\u00e9nard, D., Clain, J. & Ariey, F. Multidrug-resistant plasmodium falciparum malaria in the greater mekong subregion. Lancet Infect. Dis. 18, 238\u2013239 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"73692_CR16","doi-asserted-by":"publisher","first-page":"e23875","DOI":"10.1371\/journal.pone.0023875","volume":"6","author":"PE Ferreira","year":"2011","unstructured":"Ferreira, P. E. et al. PfMDR1: mechanisms of transport modulation by functional polymorphisms. PLOS One 6, e23875 (2011).","journal-title":"PLOS One"},{"key":"73692_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1083\/jcb.113.5.1033","volume":"113","author":"AF Cowman","year":"1991","unstructured":"Cowman, A. F., Karcz, S., Galatis, D. & Culvenor, J. G. A P-glycoprotein homologue of plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113, 1033\u20131042 (1991).","journal-title":"J. Cell Biol."},{"key":"73692_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price, R. N. et al. Mefloquine resistance in plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438\u2013447 (2004).","journal-title":"Lancet"},{"key":"73692_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock, D. A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6, 861\u2013871 (2000).","journal-title":"Mol. Cell"},{"key":"73692_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga, M. I. et al. Globally prevalent PfMDR1 mutations modulate plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat. Commun. 7, 11553 (2016).","journal-title":"Nat. Commun."},{"key":"73692_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"ABS Sidhu","year":"2006","unstructured":"Sidhu, A. B. S. et al. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528\u2013535 (2006).","journal-title":"J. Infect. Dis."},{"key":"73692_CR22","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1038\/sj.emboj.7600681","volume":"24","author":"V Lakshmanan","year":"2005","unstructured":"Lakshmanan, V. et al. A critical role for PfCRT K76T in plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J. 24, 2294\u20132305 (2005).","journal-title":"EMBO J."},{"key":"73692_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","volume":"403","author":"MB Reed","year":"2000","unstructured":"Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K. & Cowman, A. F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in plasmodium falciparum. Nature 403, 906\u2013909 (2000).","journal-title":"Nature"},{"key":"73692_CR24","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1128\/AAC.49.6.2180-2188.2005","volume":"49","author":"TJC Anderson","year":"2005","unstructured":"Anderson, T. J. C. et al. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob. Agents Chemother. 49, 2180\u20132188 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73692_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cmdc.201600298","volume":"11","author":"C Boss","year":"2016","unstructured":"Boss, C. et al. Discovery and characterization of ACT-451840: an antimalarial drug with a novel mechanism of action. ChemMedChem 11, 1995\u20132014 (2016).","journal-title":"ChemMedChem"},{"key":"73692_CR26","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M113.453159","volume":"288","author":"R Brunner","year":"2013","unstructured":"Brunner, R. et al. UV-triggered affinity capture identifies interactions between the plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells. J. Biol. Chem. 288, 22576\u201322583 (2013).","journal-title":"J. Biol. Chem."},{"key":"73692_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002138","volume":"13","author":"AL Bihan","year":"2016","unstructured":"Bihan, A. L. et al. Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose\u2013efficacy modeling. PLoS Med 13, e1002138 (2016).","journal-title":"PLoS Med"},{"key":"73692_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/infdis\/jis418","volume":"206","author":"R Brunner","year":"2012","unstructured":"Brunner, R. et al. Identification of a new chemical class of antimalarials. J. Infect. Dis. 206, 735\u2013743 (2012).","journal-title":"J. Infect. Dis."},{"key":"73692_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/mmi.13397","volume":"101","author":"CL Ng","year":"2016","unstructured":"Ng, C. L. et al. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs. Mol. Microbiol. 101, 381\u2013393 (2016).","journal-title":"Mol. Microbiol."},{"key":"73692_CR30","doi-asserted-by":"crossref","unstructured":"Gil, J. P. & Krishna, S. PFMDR1 (plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies. Expert Rev. Anti Infect. Ther. 15, 527\u2013543 (2017).","DOI":"10.1080\/14787210.2017.1313703"},{"key":"73692_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219905120","volume":"120","author":"K Si","year":"2023","unstructured":"Si, K. et al. The structure of Plasmodium falciparum multidrug resistance protein 1 reveals an N-terminal regulatory domain. Proc. Natl. Acad. Sci. USA 120, e2219905120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73692_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-biophys-111622-091232","volume":"52","author":"A Alam","year":"2023","unstructured":"Alam, A. & Locher, K. P. Structure and mechanism of human ABC transporters. Annu. Rev. Biophys. 52, 275\u2013300 (2023).","journal-title":"Annu. Rev. Biophys."},{"key":"73692_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58561-4","volume":"16","author":"AT Culbertson","year":"2025","unstructured":"Culbertson, A. T. & Liao, M. Cryo-EM of human P-glycoprotein reveals an intermediate occluded conformation during active drug transport. Nat. Commun. 16, 3619 (2025).","journal-title":"Nat. Commun."},{"key":"73692_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aav7102","volume":"363","author":"A Alam","year":"2019","unstructured":"Alam, A., Kowal, J., Broude, E., Roninson, I. & Locher, K. P. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science 363, 753\u2013756 (2019).","journal-title":"Science"},{"key":"73692_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1126\/science.aar7389","volume":"359","author":"Y Kim","year":"2018","unstructured":"Kim, Y. & Chen, J. Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science 359, 915\u2013919 (2018).","journal-title":"Science"},{"key":"73692_CR36","doi-asserted-by":"publisher","first-page":"149855","DOI":"10.1016\/j.bbrc.2024.149855","volume":"709","author":"N Hamaguchi-Suzuki","year":"2024","unstructured":"Hamaguchi-Suzuki, N. et al. Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules. Biochem. Biophys. Res. Commun. 709, 149855 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"73692_CR37","doi-asserted-by":"publisher","first-page":"E1973","DOI":"10.1073\/pnas.1717044115","volume":"115","author":"A Alam","year":"2018","unstructured":"Alam, A. et al. Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc. Natl. Acad. Sci. USA 115, E1973\u2013E1982 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73692_CR38","doi-asserted-by":"publisher","first-page":"26245","DOI":"10.1073\/pnas.2010264117","volume":"117","author":"K Nosol","year":"2020","unstructured":"Nosol, K. et al. Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc. Natl. Acad. Sci USA. 117, 26245\u201326253 (2020).","journal-title":"Proc. Natl. Acad. Sci USA."},{"key":"73692_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby, E. M. et al. Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol. 21, 280\u2013295 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"73692_CR40","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","volume":"8","author":"A Amambua-Ngwa","year":"2023","unstructured":"Amambua-Ngwa, A. et al. Chloroquine resistance evolution in plasmodium falciparum is mediated by the putative amino acid transporter AAT1. Nat. Microbiol. 8, 1213\u20131226 (2023).","journal-title":"Nat. Microbiol."},{"key":"73692_CR41","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1242\/jcs.016758","volume":"121","author":"AM Lehane","year":"2008","unstructured":"Lehane, A. M., Hayward, R., Saliba, K. J. & Kirk, K. A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites. J. Cell Sci. 121, 1624\u20131632 (2008).","journal-title":"J. Cell Sci."},{"key":"73692_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4269\/ajtmh.2007.76.641","volume":"76","author":"AP Alker","year":"2007","unstructured":"Alker, A. P. et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 76, 641\u2013647 (2007).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"73692_CR43","doi-asserted-by":"publisher","first-page":"125056","DOI":"10.1016\/j.ijpharm.2024.125056","volume":"669","author":"R Khemchandani","year":"2025","unstructured":"Khemchandani, R. et al. Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: comprehensive characterization, biological evaluation and stability analysis. Int. J. Pharm. 669, 125056 (2025).","journal-title":"Int. J. Pharm."},{"key":"73692_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1128\/AAC.04125-14","volume":"59","author":"S Bruderer","year":"2015","unstructured":"Bruderer, S. et al. First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity. Antimicrob. Agents Chemother. 59, 935\u2013942 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73692_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001616","volume":"20","author":"SH Shafik","year":"2022","unstructured":"Shafik, S. H., Richards, S. N., Corry, B. & Martin, R. E. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT. PLoS Biol. 20, e3001616 (2022).","journal-title":"PLoS Biol."},{"key":"73692_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39914-3","volume":"14","author":"TD Nguyen","year":"2023","unstructured":"Nguyen, T. D. et al. Preventing antimalarial drug resistance with triple artemisinin-based combination therapies. Nat. Commun. 14, 4568 (2023).","journal-title":"Nat. Commun."},{"key":"73692_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.118","volume":"2","author":"W Wilson","year":"2017","unstructured":"Wilson, W. et al. The antimalarial Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat. Microbiol. 2, 1\u20139 (2017).","journal-title":"Nat. Microbiol."},{"key":"73692_CR48","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/sj.emboj.7601203","volume":"25","author":"P Rohrbach","year":"2006","unstructured":"Rohrbach, P. et al. Genetic linkage of pfmdr1 with food vacuolar solute import in plasmodium falciparum. EMBO J. 25, 3000\u20133011 (2006).","journal-title":"EMBO J."},{"key":"73692_CR49","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.1175667","volume":"325","author":"RE Martin","year":"2009","unstructured":"Martin, R. E. et al. Chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter. Science 325, 1680\u20131682 (2009).","journal-title":"Science"},{"key":"73692_CR50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"73692_CR51","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"73692_CR52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, N. 4","year":"1994","unstructured":"Collaborative Computational Project, N. 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D. 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. Sect. D."},{"key":"73692_CR53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"73692_CR54","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375\u2013W383 (2007).","journal-title":"Nucleic Acids Res."},{"key":"73692_CR55","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock vina 1.2.0: new docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"73692_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73692-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:31:10Z","timestamp":1784676670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73692-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73692"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73692-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6893"}}